Details for New Drug Application (NDA): 020416
✉ Email this page to a colleague
The generic ingredient in FERIDEX I.V. is ferumoxides. Additional details are available on the ferumoxides profile page.
Summary for 020416
Tradename: | FERIDEX I.V. |
Applicant: | Amag Pharms Inc |
Ingredient: | ferumoxides |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 11.2MG IRON/ML | ||||
Approval Date: | Aug 30, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020416
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amag Pharms Inc | FERIDEX I.V. | ferumoxides | INJECTABLE;INJECTION | 020416-001 | Aug 30, 1996 | ⤷ Subscribe | ⤷ Subscribe |
Amag Pharms Inc | FERIDEX I.V. | ferumoxides | INJECTABLE;INJECTION | 020416-001 | Aug 30, 1996 | ⤷ Subscribe | ⤷ Subscribe |
Amag Pharms Inc | FERIDEX I.V. | ferumoxides | INJECTABLE;INJECTION | 020416-001 | Aug 30, 1996 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription